Changes in genes in the TLR signaling pathway within the lumbar spinal cord of doxycycline-inducible Tat transgenic mice following Tat induction 2254518

Abstract Introduction A common complication of human immunodeficiency virus (HIV)-1 infection is HIV neuropathy, which is often associated with poorly managed pain. The toll-like receptor (TLR) pathway is known to be involved in neuropathic pain, but its role in painful HIV neuropathy has not been investigated extensively. Tat, trans-activator of transcription, is a viral regulatory protein expressed early during HIV infection and is a key activator of HIV transcription. Following Tat induction, the glial fibrillary acidic protein (GFAP)-driven, doxycycline-inducible HIV-1 Tat transgenic (iTat) mice display neuropathy-like behaviors. A panel of approximately 200 inflammation-related genes were measured in the lumbar spinal cord of iTat mice following Tat induction via NanoString® technologies. Bioinformatic analysis identified the regulation of Tat of the TLR signaling pathway. Methods In this current study, we further examined the temporal changes of TLR-related genes within the NanoString profiling data to explore the potential involvement of TLR-mediated pathways. Genes encoding TLRs 1-9, major TLR pathway related signaling molecules, type 1 interferons, as well as the interferon-inducible proteins, were analyzed. Tat induction was achieved by treating iTat mice daily with doxycycline from days 0-13. Results We observed that of all the TLRs, TLR3 showed a significant upregulation starting from day 21, while upregulation of both TLRs2, 4 and 9 were slight and/or transient. Transient upregulation of type I interferon genes, as well as several interferon-inducible proteins, such as Ifi44, Ifit1/3, Mx1, and Oas1a, was also noted. No significant sex differences were noted for any of the genes examined. Conclusion Our results indicate an overall upregulation of TLR-mediated type I interferon responses following Tat induction. Ongoing study will determine if these changes are reflected at protein levels. The role of Type I interferon response in Tat-associated neuropathy will be further investigated in the future. Funding Source NIH/NIDA 1R21DA044886 (Cao) and NIH/NINDS 1R01NS132674 (PI Cao) Topic Categories Immune Mechanisms of Human Disease (HUM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.229
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Changes in genes in the TLR signaling pathway within the lumbar spinal cord of doxycycline-inducible Tat transgenic mice following Tat induction 2254518

Elizabeth Bean, Ling Cao, Anna Kelly
The Journal of Immunology
HIV Research and Treatment
article

Changes in genes in the TLR signaling pathway within the lumbar spinal cord of doxycycline-inducible Tat transgenic mice following Tat induction 2254518

Elizabeth Bean, Ling Cao, Anna Kelly
article en

Abstract

Abstract Introduction A common complication of human immunodeficiency virus (HIV)-1 infection is HIV neuropathy, which is often associated with poorly managed pain. The toll-like receptor (TLR) pathway is known to be involved in neuropathic pain, but its role in painful HIV neuropathy has not been investigated extensively. Tat, trans-activator of transcription, is a viral regulatory protein expressed early during HIV infection and is a key activator of HIV transcription. Following Tat induction, the glial fibrillary acidic protein (GFAP)-driven, doxycycline-inducible HIV-1 Tat transgenic (iTat) mice display neuropathy-like behaviors. A panel of approximately 200 inflammation-related genes were measured in the lumbar spinal cord of iTat mice following Tat induction via NanoString® technologies. Bioinformatic analysis identified the regulation of Tat of the TLR signaling pathway. Methods In this current study, we further examined the temporal changes of TLR-related genes within the NanoString profiling data to explore the potential involvement of TLR-mediated pathways. Genes encoding TLRs 1-9, major TLR pathway related signaling molecules, type 1 interferons, as well as the interferon-inducible proteins, were analyzed. Tat induction was achieved by treating iTat mice daily with doxycycline from days 0-13. Results We observed that of all the TLRs, TLR3 showed a significant upregulation starting from day 21, while upregulation of both TLRs2, 4 and 9 were slight and/or transient. Transient upregulation of type I interferon genes, as well as several interferon-inducible proteins, such as Ifi44, Ifit1/3, Mx1, and Oas1a, was also noted. No significant sex differences were noted for any of the genes examined. Conclusion Our results indicate an overall upregulation of TLR-mediated type I interferon responses following Tat induction. Ongoing study will determine if these changes are reflected at protein levels. The role of Type I interferon response in Tat-associated neuropathy will be further investigated in the future. Funding Source NIH/NIDA 1R21DA044886 (Cao) and NIH/NINDS 1R01NS132674 (PI Cao) Topic Categories Immune Mechanisms of Human Disease (HUM)

The Journal of ImmunologyVol. 215(Supplement_1)
University of New England (US)
Good health and well-being
Openalex Percentile: Top 9%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.